PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

New Pharmaceutical Business Line Director appointed at Matcon Ltd.

We are pleased to announce that Richard Lockwood has been appointed as our new Pharmaceutical Business Line Director, taking over from Shaun Baker who leaves Matcon after 8 years with us.
In his previous role within our Sales Team, Richard worked tirelessly to create successful markets for Matcon in South America and South Africa, with several large orders being secured in recent months.

Stephen Ball (right) congratulates Richard Lockwood
 on his new appointment

Richard has a Bachelor of Engineering in Chemical Engineering from the University of Bradford and brings 20 years’ experience in Engineering & Manufacturing Sales in the food, pharmaceuticals and oil & gas sectors to the role, having joined Matcon almost 7 years ago from Alfa Laval.
Richard will be responsible for the continued growth of the Pharmaceutical side of Matcon’s business with a continued focus in India and Bangladesh, alongside providing strategic support to our global sales teams.
Matcon’s Managing Director, Stephen Ball says “Richard’s customer centric approach is ideal as we continue to focus on our customers and solving their Material Handling problems. I am delighted that we have been able to promote Richard into this position”.
Commenting on his appointment, Richard said “This is an exciting time in Matcon’s expansion.  I look forward to helping our Global Teams increase our market share in this key strategic industry sector and continuing to build on the solid foundation laid down by the Pharmaceutical team over recent years.”

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026